Indigenous health worker support for patients with poorly controlled type 2 diabetes: study protocol for a cluster randomised controlled trial of the Mana Tū programme.

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.author Selak, Vanessa en
dc.contributor.author Stewart, Tereki en
dc.contributor.author Jiang, Yannan en
dc.contributor.author Reid, Jennifer en
dc.contributor.author Tane, Taria en
dc.contributor.author Carswell, Peter en
dc.contributor.author Harwood, Matire en
dc.date.accessioned 2019-05-27T02:39:18Z en
dc.date.issued 2018-12-14 en
dc.identifier.citation BMJ open 8(12):e019572 14 Dec 2018 en
dc.identifier.issn 2044-6055 en
dc.identifier.uri http://hdl.handle.net/2292/46551 en
dc.description.abstract INTRODUCTION:Type 2 diabetes mellitus (T2DM) and its complications are more common among Māori and Pacific people compared with other ethnic groups in New Zealand. Comprehensive and sustained approaches that address social determinants of health are required to address this condition, including culturally specific interventions. Currently, New Zealand has no comprehensive T2DM management programme for Māori or Pacific people. METHODS AND ANALYSIS:The Mana Tū programme was developed by a Māori-led collaborative of primary healthcare workers and researchers, and codesigned with whānau (patients and their families) in order to address this gap. The programme is based in primary care and has three major components: a Network hub, Kai Manaaki (skilled case managers who work with whānau with poorly controlled diabetes) and a cross-sector network of services to whom whānau can be referred to address the wider determinants of health. The Network hub supports the delivery of the intervention through training of Kai Manaaki, referrals management, cross-sector network development and quality improvement of the programme. A two-arm cluster randomised controlled trial will be conducted to evaluate the effectiveness of the Mana Tū programme among Māori, Pacific people or those living in areas of high socioeconomic deprivation who also have poorly controlled diabetes (glycated haemoglobin, HbA1c, >65 mmol/mol (8%)), compared with being on a wait list for the programme. A total of 400 participants will be included from 10 general practices (5 practices per group, 40 participants per practice). The primary outcome is HbA1c at 12 months. Secondary outcomes include blood pressure, lipid levels, body mass index and smoking status at 12 months. This protocol outlines the proposed study design and analysis methods. ETHICS AND DISSEMINATION:Ethical approval for the trial has been obtained from the New Zealand Health and Disability Ethics Committee (17/NTB/249). Findings will be presented to practices and their patients at appropriate fora, and disseminated widely through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER:ACTRN12617001276347; Pre-result. en
dc.format.medium Electronic en
dc.language eng en
dc.relation.ispartofseries BMJ open en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri https://creativecommons.org/licenses/by-nc/2.0/ en
dc.subject Humans en
dc.subject Diabetes Mellitus, Type 2 en
dc.subject Lipids en
dc.subject Treatment Outcome en
dc.subject Case-Control Studies en
dc.subject Follow-Up Studies en
dc.subject Smoking Cessation en
dc.subject Adult en
dc.subject Aged en
dc.subject Middle Aged en
dc.subject Allied Health Personnel en
dc.subject Health Services, Indigenous en
dc.subject Comprehensive Health Care en
dc.subject Patient Care Planning en
dc.subject Primary Health Care en
dc.subject New Zealand en
dc.subject Female en
dc.subject Male en
dc.subject Quality Improvement en
dc.subject Glycated Hemoglobin A en
dc.title Indigenous health worker support for patients with poorly controlled type 2 diabetes: study protocol for a cluster randomised controlled trial of the Mana Tū programme. en
dc.type Journal Article en
dc.identifier.doi 10.1136/bmjopen-2017-019572 en
pubs.issue 12 en
pubs.begin-page e019572 en
pubs.volume 8 en
dc.rights.holder Copyright: The authors en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype protocol en
pubs.subtype Research Support, Non-U.S. Gov't en
pubs.subtype Randomized Controlled Trial en
pubs.subtype Journal Article en
pubs.elements-id 758586 en
pubs.org-id Medical and Health Sciences en
pubs.org-id Population Health en
pubs.org-id Epidemiology & Biostatistics en
pubs.org-id Gen.Practice& Primary Hlthcare en
pubs.org-id Health Systems en
pubs.org-id Science en
pubs.org-id Statistics en
dc.identifier.eissn 2044-6055 en
pubs.record-created-at-source-date 2018-12-16 en
pubs.dimensions-id 30552239 en


Full text options

Find Full text

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc/2.0/ Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc/2.0/

Share

Search ResearchSpace


Advanced Search

Browse